Guidance Document: Drug Submissions Relying on Third-Party Data (Literature and Market Experience)

The objective of this document is to ensure that sponsors of SRTDs have the necessary information to satisfy the regulatory requirements under the Food and Drug Regulations with respect to safety, efficacy and quality which provides the basis of Health Canada's drug review and approval process.

Data and Resources

Additional Info

Field Value
Last Updated April 17, 2026, 22:09 (UTC)
Created April 17, 2026, 22:09 (UTC)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_published 0202-03-03 00:00:00
open_canada_keywords {"fr": ["présentations de médicaments", "données de tiers", "documentation et expérience du marché", "exigences réglementaires", "processus d'examen et d'approbation des médicaments"], "en": ["drug submissions", "third-party data", "literature and market-experience", "regulatory requirements", "drug review-and-approval process"]}
open_canada_subject ["health_and_safety"]
sensitivity_level unrestricted
title_fr Ligne directrice : Présentations de drogue fondées sur les données de tierces parties (Source documentaire et expérience de commercialisation)
update_frequency as_needed